Lim JH - Search Results

1

Tumor vessel normalization by the PI3K inhibitor HS-173 enhances drug delivery.

Kim SJ, Jung KH, Son MK, Park JH, Yan HH, Fang Z, Kang YW, Han B, Lim JH, Hong SS. Kim SJ, et al. Among authors: lim jh. Cancer Lett. 2017 Sep 10;403:339-353. doi: 10.1016/j.canlet.2017.06.035. Epub 2017 Jul 6. Cancer Lett. 2017. PMID: 28688971

2

HS-543 induces apoptosis of Imatinib-resistant chronic myelogenous leukemia with T315I mutation.

Kim SJ, Jung KH, Yan HH, Son MK, Fang Z, Ryu YL, Lee H, Lim JH, Suh JK, Kim J, Lee S, Hong S, Hong SS. Kim SJ, et al. Among authors: lim jh. Oncotarget. 2015 Jan 30;6(3):1507-18. doi: 10.18632/oncotarget.2837. Oncotarget. 2015. PMID: 25483100 Free PMC article.

3

HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer.

Rumman M, Jung KH, Fang Z, Yan HH, Son MK, Kim SJ, Kim J, Park JH, Lim JH, Hong S, Hong SS. Rumman M, et al. Among authors: lim jh. Oncotarget. 2016 Nov 22;7(47):78029-78047. doi: 10.18632/oncotarget.12871. Oncotarget. 2016. PMID: 27793006 Free PMC article.

4

Radiosensitization of the PI3K inhibitor HS-173 through reduction of DNA damage repair in pancreatic cancer.

Park JH, Jung KH, Kim SJ, Fang Z, Yan HH, Son MK, Kim J, Kang YW, Lee JE, Han B, Lim JH, Hong SS. Park JH, et al. Among authors: lim jh. Oncotarget. 2017 Dec 1;8(68):112893-112906. doi: 10.18632/oncotarget.22850. eCollection 2017 Dec 22. Oncotarget. 2017. PMID: 29348875 Free PMC article.

5

Melatonin Synergizes with Sorafenib to Suppress Pancreatic Cancer via Melatonin Receptor and PDGFR-β/STAT3 Pathway.

Fang Z, Jung KH, Yan HH, Kim SJ, Rumman M, Park JH, Han B, Lee JE, Kang YW, Lim JH, Hong SS. Fang Z, et al. Among authors: lim jh. Cell Physiol Biochem. 2018;47(5):1751-1768. doi: 10.1159/000491058. Epub 2018 Jun 28. Cell Physiol Biochem. 2018. PMID: 29953970 Free article.

6

KRAS targeting antibody synergizes anti-cancer activity of gemcitabine against pancreatic cancer.

Kang YW, Lee JE, Jung KH, Son MK, Shin SM, Kim SJ, Fang Z, Yan HH, Park JH, Han B, Cheon MJ, Woo MG, Lim JH, Kim YS, Hong SS. Kang YW, et al. Among authors: lim jh. Cancer Lett. 2018 Dec 1;438:174-186. doi: 10.1016/j.canlet.2018.09.013. Epub 2018 Sep 11. Cancer Lett. 2018. PMID: 30217561

7

HS-173 as a novel inducer of RIP3-dependent necroptosis in lung cancer.

Park JH, Jung KH, Kim SJ, Yoon YC, Yan HH, Fang Z, Lee JE, Lim JH, Mah S, Hong S, Kim YS, Hong SS. Park JH, et al. Among authors: lim jh. Cancer Lett. 2019 Mar 1;444:94-104. doi: 10.1016/j.canlet.2018.12.006. Epub 2018 Dec 21. Cancer Lett. 2019. PMID: 30583075

8

An Integrative Data Mining and Omics-Based Translational Model for the Identification and Validation of Oncogenic Biomarkers of Pancreatic Cancer.

Long NP, Jung KH, Anh NH, Yan HH, Nghi TD, Park S, Yoon SJ, Min JE, Kim HM, Lim JH, Kim JM, Lim J, Lee S, Hong SS, Kwon SW. Long NP, et al. Among authors: lim j, lim jh. Cancers (Basel). 2019 Jan 29;11(2):155. doi: 10.3390/cancers11020155. Cancers (Basel). 2019. PMID: 30700038 Free PMC article.

9

PBT-6, a Novel PI3KC2γ Inhibitor in Rheumatoid Arthritis.

Kim J, Jung KH, Yoo J, Park JH, Yan HH, Fang Z, Lim JH, Kwon SR, Kim MK, Park HJ, Hong SS. Kim J, et al. Among authors: lim jh. Biomol Ther (Seoul). 2020 Mar 1;28(2):172-183. doi: 10.4062/biomolther.2019.153. Biomol Ther (Seoul). 2020. PMID: 31739383 Free PMC article.

10

SB365 induces apoptosis and suppresses proliferation of glioblastoma cells.

Lim JH, Jung KH, Kim MS, You JH, Park IS, Hong SS. Lim JH, et al. Indian J Pharmacol. 2020 Mar-Apr;52(2):102-107. doi: 10.4103/ijp.IJP_117_19. Epub 2020 Jun 3. Indian J Pharmacol. 2020. PMID: 32565597 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,223 results

Search Page

Filters